RAZTRO Trademark

Trademark Overview

On Wednesday, December 10, 2014, a trademark application was filed for RAZTRO with the United States Patent and Trademark Office. The USPTO has given the RAZTRO trademark a serial number of 86476338. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 20, 2018. This trademark is owned by Glaxo Group Limited. The RAZTRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
raztro

General Information

Serial Number86476338
Word MarkRAZTRO
Filing DateWednesday, December 10, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 20, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 15, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, August 20, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 20, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, November 18, 2017EXTENSION 5 GRANTED
Friday, November 10, 2017EXTENSION 5 FILED
Friday, November 10, 2017TEAS EXTENSION RECEIVED
Saturday, July 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 29, 2017EXTENSION 4 GRANTED
Thursday, June 29, 2017EXTENSION 4 FILED
Thursday, June 29, 2017TEAS EXTENSION RECEIVED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, December 18, 2016EXTENSION 3 GRANTED
Tuesday, December 6, 2016EXTENSION 3 FILED
Tuesday, December 6, 2016TEAS EXTENSION RECEIVED
Saturday, August 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 5, 2016EXTENSION 2 GRANTED
Wednesday, June 29, 2016EXTENSION 2 FILED
Friday, July 29, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 29, 2016TEAS EXTENSION RECEIVED
Wednesday, December 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 21, 2015EXTENSION 1 GRANTED
Monday, December 21, 2015EXTENSION 1 FILED
Monday, December 21, 2015TEAS EXTENSION RECEIVED
Tuesday, July 14, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 19, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 10, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 10, 2015ASSIGNED TO LIE
Thursday, March 19, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 18, 2015ASSIGNED TO EXAMINER
Monday, December 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 13, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

raztro pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological